NASDAQ: AEGR
Price:
30.55
Change:
- 0.09
Day High:
31.02
Day Low:
30.08
Volume:
805,900
4:00 PM ET on Aug 29, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Overview

Stock price graph

Aegerion Pharmaceuticals is an emerging biopharmaceutical company focused on the development and commercialization of novel life-altering therapeutics for rare and often fatal diseases. 

Recent News

Germany's Federal Joint Committee (G-BA) grants LOJUXTA® (lomitapide) hard capsules a "no additional benefit" assessment based upon technical matters within the value dossier submitted. As expected, the decision is consistent with G-BA's preliminary assessment granted in March of this year. The Company plans to re-submit the dossier following the expiration of the decision on June 15, 2015.

View all »   RSSRecent Releases

Aug 27, 2014
Aegerion Pharmaceuticals Announces Resolution of Warning Letter for JUXTAPID(R) (lomitapide) Capsules

Aug 12, 2014
Aegerion Pharmaceuticals, Inc. Prices $300 Million Convertible Senior Notes Offering

Latest Annual Report

2013 Annual Report